Ubs Group Ag Selecta Biosciences Inc Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$0.62 - $0.85 $8,889 - $12,187
-14,338 Reduced 10.88%
117,426 $98,000
Q4 2023

Feb 09, 2024
BUY
$0.67 - $1.35 $47,880 - $96,476
71,464 Added 118.51%
131,764 $90,000
Q3 2023

Nov 09, 2023
SELL
$1.02 - $1.23 $3,379 - $4,074
-3,313 Reduced 5.21%
60,300 $63,000
Q2 2023

Aug 11, 2023
BUY
$1.04 - $1.4 $66,157 - $89,058
63,613 New
63,613 $71,000
Q3 2022

Nov 10, 2022
BUY
$1.33 - $2.6 $14,765 - $28,865
11,102 New
11,102 $18,000
Q2 2022

Aug 10, 2022
SELL
$0.67 - $1.4 $784 - $1,639
-1,171 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.23 - $3.31 $29,668 - $79,840
-24,121 Reduced 95.37%
1,171 $1,000
Q4 2021

Feb 14, 2022
SELL
$2.89 - $4.43 $359,351 - $550,839
-124,343 Reduced 83.1%
25,292 $82,000
Q3 2021

Nov 15, 2021
BUY
$3.36 - $4.62 $483,537 - $664,864
143,910 Added 2513.71%
149,635 $622,000
Q2 2021

Aug 13, 2021
SELL
$2.82 - $5.01 $823,648 - $1.46 Million
-292,074 Reduced 98.08%
5,725 $24,000
Q1 2021

May 12, 2021
BUY
$2.92 - $5.07 $869,281 - $1.51 Million
297,699 Added 297699.0%
297,799 $1.35 Million
Q4 2020

Feb 11, 2021
SELL
$1.64 - $3.42 $464 - $967
-283 Reduced 73.89%
100 $0
Q3 2020

Nov 12, 2020
SELL
$2.18 - $2.84 $68,643 - $89,425
-31,488 Reduced 98.8%
383 $1,000
Q2 2020

Jul 31, 2020
BUY
$1.83 - $4.06 $58,323 - $129,396
31,871 New
31,871 $91,000
Q4 2019

Feb 14, 2020
SELL
$1.32 - $2.47 $5,141 - $9,620
-3,895 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$1.6 - $2.08 $6,193 - $8,051
3,871 Added 16129.17%
3,895 $7,000
Q2 2019

Aug 14, 2019
SELL
$1.79 - $3.05 $162 - $277
-91 Reduced 79.13%
24 $0
Q1 2019

May 14, 2019
SELL
$1.47 - $3.06 $15,918 - $33,136
-10,829 Reduced 98.95%
115 $0
Q4 2018

Feb 14, 2019
BUY
$2.66 - $15.93 $7,445 - $44,588
2,799 Added 34.36%
10,944 $29,000
Q3 2018

Nov 14, 2018
BUY
$12.07 - $16.0 $54,942 - $72,832
4,552 Added 126.69%
8,145 $126,000
Q2 2018

Aug 14, 2018
BUY
$9.36 - $13.25 $7,235 - $10,242
773 Added 27.41%
3,593 $48,000
Q1 2018

May 15, 2018
SELL
$8.49 - $11.82 $2,801 - $3,900
-330 Reduced 10.48%
2,820 $29,000
Q4 2017

Feb 14, 2018
BUY
$8.97 - $23.38 $3,731 - $9,726
416 Added 15.22%
3,150 $31,000
Q3 2017

Nov 14, 2017
BUY
$15.22 - $20.03 $7,731 - $10,175
508 Added 22.82%
2,734 $50,000
Q2 2017

Aug 14, 2017
SELL
N/A
-69,135 Reduced 96.88%
2,226 $44,000
Q1 2017

Nov 14, 2017
BUY
N/A
71,361
71,361 $1.02 Million

Others Institutions Holding SELB

# of Institutions
5
Shares Held
4.67M
Call Options Held
0
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email